Smartlens, Inc. raises $5.2M in bridge funding, led by Ambit Health Ventures, to advance FDA clearance for innovative glaucoma management devices.
Amount Raised
$5.2 Million
Round Type
Funding Round
Mountain ViewManufacturingInformation TechnologyBiotechnologyHealth CareTherapeuticsInvestors
Description
Smartlens, Inc. closed a $5.2M bridge funding round to support its next-generation glaucoma management devices. The round was led by Ambit Health Ventures, with participation from Graphene Ventures, Boutique Venture Partners, and Harvard Business School Alumni Angels GNY. The funds will be used to advance the FDA clearance process and prepare for market launch
Who to call at Smartlens, and when
A new round usually means Smartlens is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Smartlens raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Smartlens, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Smartlens. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Smartlens raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Smartlens raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.